Physician profile
Cory Barrat
NPI 1336450840
$45,649.15
in general payments reported to CMS, 2019-2025
25 companies · $142 in 2025
The $142 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $26K · 2021: $655 · 2022: $3,007 · 2023: $324 · 2024: $174 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $600 · Consulting Fee: $40.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $599.87 |
| Consulting Fee | $40.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $38,397.57 | 2019-2020 | |
| Baxter Healthcare | $1,537.37 | 2020-2023 | Tisseel, Perclot |
| Axonics, INC. | $1,111.10 | 2020-2024 | Axonics |
| Davol INC. | $1,023.48 | 2020-2023 | Phasix Mesh |
| Intuitive Surgical, INC. | $860.77 | 2019-2025 | |
| Hill-Rom Services, INC | $650.00 | 2019 | |
| Medtronic, INC. | $598.51 | 2021-2024 | Interstim, Surgipro Ll |
| Stryker Corporation | $357.65 | 2019-2020 | |
| Tela Bio, INC. | $250.18 | 2022 | |
| Integra Lifesciences Corporation | $190.42 | 2021-2024 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Ethicon US, LLC | $118.32 | 2019-2025 | Proximate |
| Sanara Medtech INC. | $112.48 | 2022 | |
| Mentor Worldwide LLC | $89.24 | 2020-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Boston Scientific Corporation | $77.38 | 2025 | Axonics |
| Takeda Pharmaceuticals U.S.A., INC. | $39.45 | 2021-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $36.54 | 2019-2022 | |
| Steris Corporation | $33.85 | 2019 | |
| Dilon Technologies, INC. | $32.86 | 2024-2025 | Hemoblast Bellows |
| Merck Sharp & Dohme LLC | $32.32 | 2021-2023 | Keytruda |
| Braintree Laboratories, INC. | $21.18 | 2022 | |
| Smith+Nephew, INC. | $20.18 | 2019 | |
| Lexington Medical, INC. | $16.60 | 2022 | |
| Bsn Medical INC | $16.46 | 2022 | |
| Avanos Medical | $16.01 | 2025 | On-Q Pump and Accessories |
| Musculoskeletal Transplant Foundation INC. | $9.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cory Barrat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.